Andolfi, C. Et Al. 2024. MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer. Endocrinology (United States) , vol.165, no.10 .

Andolfi, C., Bartolini, C., Morales, E., Gündoğdu, B., Puhr, M., Guzman, J., ... Wach, S.(2024). MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer. Endocrinology (United States) , vol.165, no.10.

Andolfi, Chiara Et Al. "MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer," Endocrinology (United States) , vol.165, no.10, 2024

Andolfi, Chiara Et Al. "MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer." Endocrinology (United States) , vol.165, no.10, 2024

Andolfi, C. Et Al. (2024) . "MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer." Endocrinology (United States) , vol.165, no.10.

@article{article, author={Chiara Andolfi Et Al. }, title={MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate Cancer}, journal={Endocrinology (United States)}, year=2024}